Strikingly, State_4 markers correlated with poor lung cancer prognosis, while State_3 markers associated with better outcomes (Figure S20E and Data S39), implying CD27+ B cells differentiate into malignant State_4 subsets. Here, CD27 is linked to lung cancer.